(Q37171429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Recurrence of high-risk bladder cancer: a population-based analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

8

Christopher S Saigal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

2

Mark S Litwin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

Urologic Diseases in America Project

2 March 2020

9

object named as

Urologic Diseases in America Project

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Karim Chamie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Timothy J Daskivich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Julie Lai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jan M Hanley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Badrinath R Konety

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

4 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

3219-3227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

Quality of care in patients with bladder cancer: a case report?

2 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Compliance with guidelines for patients with bladder cancer: variation in the delivery of care

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Establishment of a urological surgery quality collaborative

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Understanding bladder cancer death: tumor biology versus physician practice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Defining optimal therapy for muscle invasive bladder cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Development of a comorbidity index using physician claims data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

The regionalization of radical cystectomy to specific medical centers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Understanding the use of immediate intravesical chemotherapy for patients with bladder cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773281

Treatment of Muscle Invasive Bladder Cancer: Evidence From the National Cancer Database, 2003 to 2007

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.28147

Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older

21 January 2018

1 reference

12 December 2020

Superficial bladder cancer: progression and recurrence

1 reference

12 December 2020

Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?

1 reference

12 December 2020

Grading in superficial bladder cancer. (1). Morphological criteria

1 reference

12 December 2020

Should pT1 transitional cell cancers of the bladder still be classified as superficial?

1 reference

12 December 2020

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

12 December 2020

The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study

1 reference

12 December 2020

Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome

1 reference

12 December 2020

The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy

1 reference

12 December 2020

The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.28147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737352%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

23737352

1 reference